These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32315497)

  • 1. Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo-Controlled, Phase II Trial.
    Niemeyer-van der Kolk T; van der Wall H; Hogendoorn GK; Rijneveld R; Luijten S; van Alewijk DCJG; van den Munckhof EHA; de Kam ML; Feiss GL; Prens EP; Burggraaf J; Rissmann R; van Doorn MBA
    Clin Transl Sci; 2020 Sep; 13(5):994-1003. PubMed ID: 32315497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial.
    Niemeyer-van der Kolk T; Buters TP; Krouwels L; Boltjes J; de Kam ML; van der Wall H; van Alewijk DCJG; van den Munckhof EHA; Becker MJ; Feiss G; Florencia EF; Prens EP; Moerland M; Burggraaf J; Rissmann R; van Doorn MBA
    J Am Acad Dermatol; 2022 Apr; 86(4):854-862. PubMed ID: 33010325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.
    Lee YW; Won CH; Jung K; Nam HJ; Choi G; Park YH; Park M; Kim B
    Br J Dermatol; 2019 May; 180(5):1030-1038. PubMed ID: 30623408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study.
    Hanifin JM; Ellis CN; Frieden IJ; Fölster-Holst R; Stein Gold LF; Secci A; Smith AJ; Zhao C; Kornyeyeva E; Eichenfield LF
    J Am Acad Dermatol; 2016 Aug; 75(2):297-305. PubMed ID: 27189825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis.
    Gonzalez ME; Schaffer JV; Orlow SJ; Gao Z; Li H; Alekseyenko AV; Blaser MJ
    J Am Acad Dermatol; 2016 Sep; 75(3):481-493.e8. PubMed ID: 27543211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.
    Kabashima K; Matsumura T; Komazaki H; Kawashima M;
    N Engl J Med; 2020 Jul; 383(2):141-150. PubMed ID: 32640132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Cutaneous Microbiota in Atopic Dermatitis by Coal Tar via AHR-Dependent Induction of Antimicrobial Peptides.
    Smits JPH; Ederveen THA; Rikken G; van den Brink NJM; van Vlijmen-Willems IMJJ; Boekhorst J; Kamsteeg M; Schalkwijk J; van Hijum SAFT; Zeeuwen PLJM; van den Bogaard EH
    J Invest Dermatol; 2020 Feb; 140(2):415-424.e10. PubMed ID: 31344386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial).
    Totté J; de Wit J; Pardo L; Schuren F; van Doorn M; Pasmans S
    Trials; 2017 Aug; 18(1):404. PubMed ID: 28859690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new topical treatment of atopic dermatitis in pediatric patients based on Ficus carica L. (Fig): A randomized, placebo-controlled clinical trial.
    Abbasi S; Kamalinejad M; Babaie D; Shams S; Sadr Z; Gheysari M; Askari VR; Rakhshandeh H
    Complement Ther Med; 2017 Dec; 35():85-91. PubMed ID: 29154073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment of atopic dermatitis with St. John's wort cream--a randomized, placebo controlled, double blind half-side comparison.
    Schempp CM; Windeck T; Hezel S; Simon JC
    Phytomedicine; 2003; 10 Suppl 4():31-7. PubMed ID: 12807340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apple cider vinegar soaks do not alter the skin bacterial microbiome in atopic dermatitis.
    Luu LA; Flowers RH; Gao Y; Wu M; Gasperino S; Kellams AL; Preston DC; Zlotoff BJ; Wisniewski JA; Zeichner SL
    PLoS One; 2021; 16(6):e0252272. PubMed ID: 34077434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
    Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
    Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes encapsulating novel antimicrobial peptide Omiganan: Characterization and its pharmacodynamic evaluation in atopic dermatitis and psoriasis mice model.
    Javia A; Misra A; Thakkar H
    Int J Pharm; 2022 Aug; 624():122045. PubMed ID: 35878872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties.
    Capone K; Kirchner F; Klein SL; Tierney NK
    J Drugs Dermatol; 2020 May; 19(5):524-531. PubMed ID: 32484623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group.
    Drake LA; Fallon JD; Sober A
    J Am Acad Dermatol; 1994 Oct; 31(4):613-6. PubMed ID: 8089287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double blinded, vehicle controlled, crossover study on the efficacy of a topical endocannabinoid membrane transporter inhibitor in atopic Beagles.
    Marsella R; Ahrens K; Sanford R; Trujillo A; Massre D; Soeberdt M; Abels C
    Arch Dermatol Res; 2019 Dec; 311(10):795-800. PubMed ID: 31446453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of a cream containing AR-GG27® (sorbityl furfural palmitate) in the treatment of mild/moderate childhood atopic dermatitis associated with pityriasis alba. A double-blind, placebo-controlled clinical trial.
    Patrizi A; Raone B; Raboni R; Neri I
    G Ital Dermatol Venereol; 2012 Dec; 147(6 Suppl 1):1-8. PubMed ID: 23007324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo responses in randomized controlled trials for systemic therapy in atopic dermatitis: A systematic review and meta-analysis.
    Lee HH; Patel KR; Rastogi S; Singam V; Vakharia PP; Chopra R; Silverberg JI
    J Am Acad Dermatol; 2020 Jan; 82(1):62-71. PubMed ID: 31202874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.